USPTO serial 97614233
INTELLIPGMI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 17, 2025
- Examiner
- WATSON, JULIE A
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with INTELLIPGMI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Halifax, Nova Scotia, CA
Halifax, Nova Scotia, CA
Halifax, Nova Scotia, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey R. Cadwell
Jeffrey R. Cadwell DORSEY & WHITNEY LLP50 SOUTH SIXTH STREETSUITE 1500MINNEAPOLIS, MN 55402-1498Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer hardware and recorded software for operating medical imaging apparatus sold as a unit; Downloadable software for processing digital images of the anatomy for diagnosis and treatment; Downloadable software for processing images, graphics and text; downloadable CAD/CAM software for medical screening and diagnosis, namely for medical diagnostic imaging for use in cancer diagnosis, and to facilitate better image quality of medical diagnostic imagery, breast imaging, screening measurement of clinical image quality; downloadable cloud-based software for medical screening and diagnosis, namely for medical diagnostic imaging for use in cancer diagnosis, and to facilitate better image quality of medical diagnostic imagery, breast imaging, screening measurement of clinical image quality; downloadable computer software for controlling and managing patient medical information; downloadable computer software for organizing and viewing digital images; downloadable medical software for processing and displaying images on x-ray and ultrasound medical imaging machines; computer software for clinical workflows and clinical tasks management, treatment of patients and healthcare administration, namely for medical diagnostic imaging for use in cancer diagnosis, and to facilitate better image quality of medical diagnostic imagery, breast imaging, screening measurement of clinical image quality; recorded medical software for screening and diagnosis imaging interpretation; downloadable and recorded computer software for medical diagnostic imaging for use in cancer diagnosis and cancer treatment; downloadable and recorded computer software for medical diagnostic imaging; downloadable and recorded computer software for medical diagnostic imaging for use in health information systems for receiving, processing, transmitting, and displaying patient medical data, including, diagnostic test results, diagnostic medical images, and patient personal data, and controlling and managing patient health information; downloadable and recorded computer software for processing and analysis of radiological images for medical diagnostic imaging; downloadable and recorded computer software in the field of medical diagnostic imaging for managing quality control, namely, training of medical staff; downloadable and recorded computer software, for medical diagnostic imaging using algorithms, to facilitate the comparison of metrics, medical and healthcare analytics and informatics, and data capture, and clinical decision tools; computers and tablet computers for medical use, use with x-ray machines, use for medical diagnosis, use for imaging purposes; downloadable and recorded computer software for quality control, namely, computer software for use in controlling quality of diagnostic medical images, and for providing quality assurance in medical screening for diagnostic and treatment purposes in medical screening for diagnostic and treatment purposes | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software for medical screening and diagnosis, namely for medical diagnostic imaging for use in clinical image quality assessment in cancer diagnosis; design, development and implementation of software; image processing software design; research and development of computer software; software research, development, engineering, design, installation, creation for medical diagnostic imaging; software research, development, engineering, design, installation, creation in the fields of medicine, health, disease, oncology, and radiology for medical diagnostic imaging; medical technology development and research in the field of medical diagnostic imaging; platform as a service (PAAS) featuring computer software for medical diagnostic imaging for use in cancer diagnosis and cancer treatment; platform as a service (PAAS) featuring computer software for medical diagnostic imaging, namely for medical diagnostic imaging for use in clinical image quality assessment in cancer diagnosis; platform as a service (PAAS) featuring computer software platforms for medical diagnostic imaging, namely, software to facilitate better image quality of medical diagnostic imagery, breast imaging, screening measurement of breast density, and breast cancer; software as service (SAAS) services featuring software for use in the fields of medicine, health and disease, namely, software to facilitate better image quality of medical diagnostic imagery in breast imaging and screening, and measurement of breast density, and breast cancer risk; platform as a service (PAAS) featuring computer software for medical diagnostic imaging for use in health information systems for receiving, processing, transmitting, and displaying patient medical data, namely, diagnostic test results, diagnostic medical images, and patient personal data, and controlling and managing patient health information; software design in the field of medical diagnostic imaging; medical software design in the field of medical diagnostic imaging; research services in the fields of medicine, health care, disease, oncology, and radiology | ACTIVE | — |
| 044 | Providing medical information to patients and medical professionals in the form of downloadable medical reports in the field of medical diagnostic imaging for patient care and medical clinic operations, for display on computer screens | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Densitas Inc.
- Other trademarks owned by Densitas Inc.
- Other trademarks owned by Densitas Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named INTELLIPGMI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 17, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 17, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 29, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 29, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 1, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 12, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 12, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Dec 12, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Dec 12, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 8, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 8, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 8, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 15, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 15, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 15, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 13, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jul 17, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 4, 2022 | NWAP | NEW APPLICATION ENTERED | — |